Tarsons Products Share Price Today (TARSONS)
Today’s Tarsons Stock Read
Tarsons Products is trading up 0.3% at ₹259.03. With a market cap of ₹1,385.49 Cr, it trades at a P/E of 96.80. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Tarsons Products is trading up 0.3% at ₹259.03. With a market cap of ₹1,385.49 Cr, it trades at a P/E of 96.80. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Tarsons Products Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Tarsons Products Limited, framed against the sector median so the premium or discount is obvious at a glance.
Tarsons Products Limited trades at a P/E of 96.80× and P/B of 2.18×.
Valuation
Profitability
Growth
Financial Health
Tarsons Products Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Tarsons Products Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Tarsons Products Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Tarsons Products Limited, switchable between annual and quarterly views, consolidated or standalone.
Tarsons Products Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,385.49 Cr and reported EPS of ₹2.69.
| Period | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue from Operations | 301 | 296 | 392 | 423 |
| Other Income | 8 | 11 | 16 | 24 |
| Total Income | 309 | 308 | 408 | 447 |
| Cost of Goods Sold (COGS) | 63 | 82 | 129 | 139 |
| Gross Profit | 238 | 214 | 263 | 284 |
| +Operating Expenses | 85 | 114 | 152 | 166 |
| EBITDA | 153 | 100 | 111 | 118 |
| +Non-Operating Expenses | 26 | 51 | 82 | 118 |
| Profit Before Tax (PBT) | 135 | 61 | 45 | 22 |
| +Tax Expense | 34 | 18 | 15 | 8 |
| Total Profit for Period | 101 | 43 | 30 | 14 |
| Net Profit (Owner's PAT) | 101 | 43 | 30 | 14 |
| Earnings Per Share (EPS) | 18.92 | 8.01 | 5.60 | 2.69 |
| Diluted Shares Outstanding (Nos.) | 5 | 5 | 5 | 5 |
| +Additional Disclosures | 237 | 330 | 491 | 553 |
| Sales Growth % | — | -1.46 | 32.40 | 7.67 |
| YoY Sales Growth % | — | — | 32.40 | 7.67 |
| Material Cost % | 23 | 21 | 20 | 17 |
| Employee Cost % | 10 | 15 | 17 | 18 |
| Other Cost % | 18 | 24 | 22 | 21 |
| OPM % | 51 | 34 | 28 | 28 |
| Tax % | 25 | 30 | 34 | 35 |
| Profit Growth % | — | — | -30.18 | -51.89 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 131 | 59 | 48 | 21 |
Tarsons Products segment analysis: revenue and profit mix.
Disclosed business segments at Tarsons Products with their share of revenue and profit, switchable between consolidated and standalone reporting.
Tarsons Products discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Tarsons Products Limited.
Our AI distills the core fundamental drivers supporting Tarsons Products Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Tarsons Products Limited's investment case rests on 9 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Robust operating profit margin (OPM) of 29.20% indicates strong operational efficiency.
Low debt-to-equity ratio of 0.54 signifies a conservative financial structure.
Significant promoter holding of 47.3% demonstrates strong insider confidence.
Positive quarterly sales growth of 7.74% indicates increasing market demand.
Extensive product portfolio in scientific plastic labware serves diverse needs.
What can break it.
High Price-to-Earnings (P/E) ratio of 55.90 suggests potential overvaluation.
Low Return on Equity (ROE) of 4.75% indicates inefficient capital utilization.
Substantial quarterly profit decline of -55.70% raises profitability concerns.
Low Return on Capital Employed (ROCE) of 6.91% suggests inefficient asset utilization.
Significant stock volatility, trading between ₹465.00 high and ₹280.00 low.
What would change my mind.
Trim if P/E re-rates above 126. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.12. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Tarsons Products Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Tarsons Products Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Tarsons Products Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Tarsons Products Limited — derived from the live tape, not yesterday's close.
Tarsons Products Limited last traded at ₹259.03 with an intraday range of ₹248.22–₹264.5 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹259.03| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 298.84 | +39.81 | +15.37% |
| R3 | 282.56 | +23.53 | +9.08% |
| R2 | 273.53 | +14.50 | +5.60% |
| R1 | 266.28 | +7.25 | +2.80% |
| PIVOT | 257.25 | -1.78 | -0.69% |
| CURRENT | 259.03 | — | — |
| S1 | 217.44 | -41.59 | -16.06% |
| S2 | 233.72 | -25.31 | -9.77% |
| S3 | 240.97 | -18.06 | -6.97% |
| S4 | 250.00 | -9.03 | -3.49% |
TARSONS is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 257.47 ~ 262
Trading Inside opening range
Tarsons Products Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Tarsons Products Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Tarsons Products Limited stood at 33.3% of traded volume, against a 20-day average of 43.6%.
Tarsons Products announcements: results, concalls, ratings, M&A.
Filings Tarsons Products sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Tarsons Products files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 72 documents below.
Spurt in Volume
Significant increase in volume has been observed in Tarsons Products Limited. The Exchange, in order to ensure that investors have latest relevant…
Analysts/Institutional Investor Meet/Con. Call Updates
Tarsons Products Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Tarsons Products Limited has informed the Exchange about Schedule of meet
Analysts/Institutional Investor Meet/Con. Call Updates
Tarsons Products Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
Tarsons Products Limited has informed the Exchange about Copy of Newspaper Publication
Investor decks & rating reports.
Tarsons Products dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Tarsons Products has declared, sequenced by announce and record date.
Tarsons Products corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Tarsons Products Limited: business, sector, key facts.
What Tarsons Products Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Tarsons Products Limited operates in the Medical Equipment & Supplies industry under the Healthcare sector, listed as NSE: TARSONS, BSE: 543399.
Tarsons Products Limited is a prominent Indian manufacturer and trader specializing in scientific plastic labware. Their product portfolio is extensive and caters to a wide range of laboratory needs across various scientific disciplines. The company's primary focus is on providing high-quality, reliable plastic consumables for research and laboratory applications both domestically and internationally.
The company's product catalog includes a comprehensive selection of items used in diverse laboratory settings. This includes a wide variety of containers such as bottles, carboys, boxes, racks, centrifuge tubes, vials, and cryogenic storage solutions like boxes and canes. They also offer a substantial range of specialized labware for specific techniques like cell culture (flasks, petri dishes), electrophoresis (power supplies, gel casting units), and sample handling (microscopic slide storage, staining kits).
Beyond basic containers, Tarsons provides a broad array of instruments and accessories crucial for laboratory operation. This encompasses items like liquid handling tools, incubation trays, safety equipment (gloves, safety goggles, biohazardous waste containers), and general labware such as forceps, scoops, and tubing. Their product range also includes specialized items for PCR, molecular biology, and other advanced laboratory procedures.
Tarsons' products find applications across several key scientific fields, including molecular biology, cell culture, genomics, proteomics, and immunology. The company's commitment to quality and comprehensive product offering has established its position as a significant player in the Indian and international scientific labware market. Established in 1983 and headquartered in Kolkata, India, Tarsons continues to serve the needs of researchers and laboratories worldwide.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about Tarsons Products Limited (TARSONS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Tarsons Products Limited (TARSONS)?
The current share price of Tarsons Products Limited (TARSONS) is ₹259.03. Today, the stock has gained by ₹0.77 (0.30%), trading in a range of ₹248.22 to ₹264.5. The stock opened at ₹260 with a trading volume of 72,083 shares.
02Is Tarsons Products Limited stock a good investment for long-term?
Tarsons Products Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,385.49 crores, P/E ratio of 96.80, ROE of 2.27%, and ROCE of 4.56%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Tarsons Products Limited stock?
The 52-week high price of Tarsons Products Limited (TARSONS) is ₹402.85, while the 52-week low is ₹164.45. Currently trading at ₹259.03, the stock is 39.7% away from its 52-week low and 35.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Tarsons Products Limited stock at the current price?
Whether to buy Tarsons Products Limited stock at ₹259.03 depends on multiple factors. The stock is currently trading with a P/E ratio of 96.80 and P/B ratio of 2.18. Today's performance shows a gain of 0.30%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Tarsons Products Limited and when is the next dividend?
Tarsons Products Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹259.03, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Tarsons Products Limited?
Tarsons Products Limited's key financial metrics include: P/E Ratio: 96.80, P/B Ratio: 2.18, ROE: 2.27%, ROCE: 4.56%, Dividend Yield: 0.00%, EPS: ₹2.69, Book Value: ₹119.92, and Debt-to-Equity: 0.62. The company's market cap stands at ₹1,385.49 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Tarsons Products Limited stock performing today in the market?
Tarsons Products Limited stock opened at ₹260 and is currently trading at ₹259.03, showing a gain of ₹0.77 (0.30%). The intraday high is ₹264.5 and low is ₹248.22. The trading volume stands at 72,083 shares, indicating moderate market participation today.
08What is the P/E ratio of Tarsons Products Limited and what does it indicate?
Tarsons Products Limited has a Price-to-Earnings (P/E) ratio of 96.80, which means investors are willing to pay ₹96.80 for every ₹1 of earnings. With an EPS of ₹2.69, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Tarsons Products Limited (TARSONS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.